Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-03-10 @ 4:15 AM
Study NCT ID:
NCT02398058
Status:
COMPLETED
Last Update Posted:
2021-04-14
First Post:
2015-01-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS)
Sponsor:
Italian Sarcoma Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
TOMAS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None